Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
In diabetic LDLR-/- mice, an ectopic BMP2-Msx2 gene regulatory program is upregulated in association with vascular calcification. We verified the procalcific actions of aortic Msx2 expression in vivo. CMV-Msx2 transgenic (CMV-Msx2Tg(+)) mice expressed 3-fold higher levels of aortic Msx2 than nontransgenic littermates. On high-fat diets, CMV-Msx2Tg(+) mice exhibited marked cardiovascular calcification involving aortic and coronary tunica media. This corresponded to regions of Msx2 immunoreactivity in adjacent adventitial myofibroblasts, suggesting a potential paracrine osteogenic signal. To better understand Msx2-regulated calcification, we studied actions in 10T1/2 cells. We found that conditioned media from Msx2-transduced 10T1/2 cells (Msx2-CM) is both pro-osteogenic and adipostatic; these features are characteristic of Wnt signaling. Msx2-CM stimulated Wnt-dependent TCF/LEF transcription, and Msx2-transduced cells exhibited increased nuclear beta-catenin localization with concomitant alkaline phosphatase induction. Msx2 upregulated Wnt3a and Wnt7a but downregulated expression of the canonical inhibitor Dkk1. Dkk1 treatment reversed osteogenic and adipostatic actions of Msx2. Teriparatide, a PTH1R agonist that inhibits murine vascular calcification, suppressed vascular BMP2-Msx2-Wnt signaling. Analyses of CMV-Msx2Tg(+) mice confirmed that Msx2 suppresses aortic Dkk1 and upregulates vascular Wnts; moreover, TOPGAL(+) (Wnt reporter); CMV-Msx2Tg(+) mice exhibited augmented aortic LacZ expression. Thus, Msx2-expressing cells elaborated an osteogenic milieu that promotes vascular calcification in part via paracrine Wnt signals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J. M., Behringer, R. R., & de Crombrugghe, B. (2002) · Cell · doi:10.1016/s0092-8674(01)00622-5 · Cited by 3,608
Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease
Owens, G. K., Kumar, M. S., & Wamhoff, B. R. (2004) · Physiological Reviews · doi:10.1152/physrev.00041.2003 · Cited by 3,471
Inhibition of Adipogenesis by Wnt Signaling
Ross, S. E., Hemati, N., Longo, K. A., Bennett, C. N., Lucas, P. C., Erickson, R. L., & MacDougald, O. A. (2000) · Science · doi:10.1126/science.289.5481.950 · Cited by 1,874
London, G. M. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg414 · Cited by 1,859
High Bone Density Due to a Mutation in LDL-Receptor–Related Protein 5
Boyden, L. M., Mao, J., Belsky, J., Mitzner, L., Farhi, A., Mitnick, M. A., Wu, D., Insogna, K., & Lifton, R. P. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013444 · Cited by 1,591 · cited 1×
“Since Wnts are key modulators of osteogenic mesenchymal cell fate (22, 32), we examined the effects of Msx2 CM on canonical Wnt signaling using activation of the Wnt-responsive TCF/LEF transcriptional reporter–LUC reporter, TOPFLASH (33).”
Kremen proteins are Dickkopf receptors that regulate Wnt/β-catenin signalling
Mao, B., Wu, W., Davidson, G., Marhold, J., Li, M., Mechler, B. M., Delius, H., Hoppe, D., Stannek, P., Walter, C., et al. (2002) · Nature · doi:10.1038/nature756 · Cited by 1,038
Bone morphogenetic protein expression in human atherosclerotic lesions.
Boström, K., Watson, K. E., Horn, S., Wortham, C., Herman, I. M., & Demer, L. L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116391 · Cited by 1,020
DasGupta, R., & Fuchs, E. (1999) · Development · doi:10.1242/dev.126.20.4557 · Cited by 1,000
Schäfer, C., Heiss, A., Schwarz, A., Westenfeld, R., Ketteler, M., Floege, J., Müller-Esterl, W., Schinke, T., & Jahnen-Dechent, W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17202 · Cited by 924
van Bezooijen, R. L., Roelen, B. A. J., Visser, A., van der Wee-Pals, L., de Wilt, E., Karperien, M., Hamersma, H., Papapoulos, S. E., ten Dijke, P., & Löwik, C. W. G. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031454 · Cited by 892
Cited by
Vascular Calcification: Pathobiology of a Multifaceted Disease
Demer, L. L., & Tintut, Y. (2008) · Circulation · doi:10.1161/circulationaha.107.743161 · Cited by 1,065
Lindman, B. R., Clavel, M.-A., Mathieu, P., Iung, B., Lancellotti, P., Otto, C. M., & Pibarot, P. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.6 · Cited by 982
Rajamannan, N. M., Evans, F. J., Aikawa, E., Grande-Allen, K. J., Demer, L. L., Heistad, D. D., Simmons, C. A., Masters, K. S., Mathieu, P., O'Brien, K. D., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.006767 · Cited by 842
Self-citationYahagi, K., Kolodgie, F. D., Lutter, C., Mori, H., Romero, M. E., Finn, A. V., & Virmani, R. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.116.306256 · Cited by 573
Regulatory mechanisms in vascular calcification
Sage, A. P., Tintut, Y., & Demer, L. L. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.115 · Cited by 568
Vascular calcification: Mechanisms of vascular smooth muscle cell calcification
Leopold, J. A. (2015) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2014.10.021 · Cited by 468
“Early studies performed in a rat model of CKD that underwent parathyroidectomy followed by PTH replacement therapy demonstrated significant aortic medial calcification suggesting that PTH has a direct role in promoting vascular calcification.60 Conversely, other studies that examined activation of the PTH1 receptor, w…”
BackgroundInfluentialRole and mechanism of action of sclerostin in bone
Delgado-Calle, J., Sato, A. Y., & Bellido, T. (2017) · Bone · doi:10.1016/j.bone.2016.10.007 · Cited by 443
WNT–β-catenin signalling — a versatile player in kidney injury and repair
Schunk, S. J., Floege, J., Fliser, D., & Speer, T. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00343-w · Cited by 427
Rosuvastatin Affecting Aortic Valve Endothelium to Slow the Progression of Aortic Stenosis
Moura, L. M., Ramos, S. F., Zamorano, J. L., Barros, I. M., Azevedo, L. F., Rocha-Gonçalves, F., & Rajamannan, N. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.072 · Cited by 405
Media Calcification and Intima Calcification Are Distinct Entities in Chronic Kidney Disease
Amann, K. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02120508 · Cited by 385
Yutzey, K. E., Demer, L. L., Body, S. C., Huggins, G. S., Towler, D. A., Giachelli, C. M., Hofmann-Bowman, M. A., Mortlock, D. P., Rogers, M. B., Sadeghi, M. M., et al. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.302523 · Cited by 371
Self-citationCaira, F. C., Stock, S. R., Gleason, T. G., McGee, E. C., Huang, J., Bonow, R. O., Spelsberg, T. C., McCarthy, P. M., Rahimtoola, S. H., & Rajamannan, N. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.02.040 · Cited by 371
Molecular Mechanisms of Vascular Calcification: Lessons Learned From The Aorta
Shao, J.-S., Cai, J., & Towler, D. A. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000220441.42041.20 · Cited by 348
Self-citationWNT Signaling in Cardiac and Vascular Disease
Foulquier, S., Daskalopoulos, E. P., Lluri, G., Hermans, K. C. M., Deb, A., & Blankesteijn, W. M. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.013896 · Cited by 347
Arterial calcification and bone physiology: role of the bone–vascular axis
Thompson, B., & Towler, D. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.36 · Cited by 337
Self-citationVitamin D in chronic kidney disease: A systemic role for selective vitamin D receptor activation
Andress, D. L. (2006) · Kidney International · doi:10.1038/sj.ki.5000045 · Cited by 309
Kramann, R., Goettsch, C., Wongboonsin, J., Iwata, H., Schneider, R. K., Kuppe, C., Kaesler, N., Chang-Panesso, M., Machado, F. G., Gratwohl, S., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.08.001 · Cited by 308
Al-Aly, Z., Shao, J.-S., Lai, C.-F., Huang, E., Cai, J., Behrmann, A., Cheng, S.-L., & Towler, D. A. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.153668 · Cited by 307
Self-citationAkech, J., Wixted, J. J., Bedard, K., van der Deen, M., Hussain, S., Guise, T. A., van Wijnen, A. J., Stein, J. L., Languino, L. R., Altieri, D. C., et al. (2010) · Oncogene · doi:10.1038/onc.2009.389 · Cited by 295
Pathogenesis of Calcific Aortic Valve Disease: A Disease Process Comes of Age (and a Good Deal More)
O’Brien, K. D. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000227513.13697.ac · Cited by 295
Zhu, D., Mackenzie, N. C. W., Millán, J. L., Farquharson, C., & MacRae, V. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019595 · Cited by 276
The Regulation of Valvular and Vascular Sclerosis by Osteogenic Morphogens
Boström, K. I., Rajamannan, N. M., & Towler, D. A. (2011) · Circulation Research · doi:10.1161/circresaha.110.234278 · Cited by 257
Self-citationVitamin D and the Cardiovascular System
Artaza, J. N., Mehrotra, R., & Norris, K. C. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02260409 · Cited by 194
Calcific aortic stenosis: an update
Rajamannan, N. M., Bonow, R. O., & Rahimtoola, S. H. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0827 · Cited by 176
Nakagawa, Y., Ikeda, K., Akakabe, Y., Koide, M., Uraoka, M., Yutaka, K.-T., Kurimoto-Nakano, R., Takahashi, T., Matoba, S., Yamada, H., et al. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.206185 · Cited by 124
Msx2 Exerts Bone Anabolism via Canonical Wnt Signaling
Cheng, S.-L., Shao, J.-S., Cai, J., Sierra, O. L., & Towler, D. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800851200 · Cited by 89
Self-citationCheng, S.-L., Behrmann, A., Shao, J.-S., Ramachandran, B., Krchma, K., Bello Arredondo, Y., Kovacs, A., Mead, M., Maxson, R., & Towler, D. A. (2014) · Diabetes · doi:10.2337/db14-0326 · Cited by 77
Self-citationShared gene expression profiles in developing heart valves and osteoblast progenitor cells
Chakraborty, S., Cheek, J., Sakthivel, B., Aronow, B. J., & Yutzey, K. E. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.90212.2008 · Cited by 75
The Role of Sclerostin in Bone and Ectopic Calcification
De Maré, A., D’Haese, P. C., & Verhulst, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093199 · Cited by 45
“Other mechanisms, such as upregulation of Wnt ligands [77,85] and decreased expression of Wnt inhibitors [85], however, are also involved.”
BackgroundMSX2 in ameloblast cell fate and activity
Babajko, S., de La Dure-Molla, M., Jedeon, K., & Berdal, A. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2014.00510 · Cited by 40
“The expression profiles of Msx homeobox genes may overlap; there may be redundancy between MSX1 and MSX2 as they display structural conservation, according to anatomical site (Sharpe, 1995).”
Sizing up sialic acid in glomerular disease
Quaggin, S. E. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32482 · Cited by 23
Yoon, C.-Y., Park, J., Seo, C., Nam, B. Y., Kim, S., Kee, Y. K., Lee, M., Cha, M.-U., Kim, H., Park, S., et al. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2907 · Cited by 8
Fotinos, A., Fritz, D. T., Lisica, S., Liu, Y., & Rogers, M. B. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25290 · Cited by 8
Metadata
- Authors
- Shao, J.-S., Cheng, S.-L., Pingsterhaus, J. M., Charlton-Kachigian, N., Loewy, A. P., & Towler, D. A.
- Venue
- Journal of Clinical Investigation
- Published
- 2005-04-14
- Volume
- 115
- Issue
- 5
- Pages
- 1210-1220
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2051580972
- Cited by
- 452
- References
- 57
- FWCI
- 11.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.